Gastric Balloon Weight Loss System

The Gastric Balloon — a New Option in Minimally-Invasive Bariatrics

Many people find that their weight loss experience leaves them with few choices in the gap between dieting/exercise and invasive surgery procedures.

Enter the ORBERA™ Intragastric Balloon, an exciting development for men and women who desire to reach their long-term weight loss goals with bariatric surgery options that are less-invasive.

The Orbera Managed Weight Loss System is designed to help people lose weight and maintain the weight loss. Hedden & Gunn Plastic Surgery in Birmingham, Alabama is one of the first practices in the country to offer this nonsurgical solution for men and women who struggle with excess pounds and are committed to seeing their weight loss goals become reality.

The world's #1 weight loss balloon, Orbera has helped thousands lose millions of pounds and maintain their healthy habits.

Is the Gastric Balloon Right for Me?

Acccording to the Centers for Disease Control and Prevention, more than 78% of U.S. adults are obese. This amounts to one-third of the adult population.

Candidates for the gastric balloon system must have a Body Mass Index (BMI) of 30 to 40. Men and women with a BMI in this range of obesity face an increased risk for ongoing health problems. In the past, people in this "lower BMI" range have had few weight loss options besides dieting, exercise and more-invasive bariatric surgery, which usually requires a BMI of at least 40.

People may be candidates for the Orbera Gastric Balloon if they:

• Are Adults at least 22 years of age.
• Have a BMI range of 30 to 40.
• Are willing to participate in a medically-supervised program.
• Have attempted more conservative weight reduction alternatives.

Gastric Balloon Safety and Clinical Trial

Orbera Safety Information

The Orbera Intragastric Balloon System is a weight loss aid for adults suffering from obesity who have tried other weight loss programs, such as following supervised diet, exercise and behavior modification programs, but who were unable to lose weight and keep it off. Common side effects of the Orbera Gastric Balloon include nausea, vomiting and abdominal pain. Speak to your physician about these and other more serious side effects that may occur.

Orbera Clinical Trial

The ORBERA™ clinical trial studied 255 bariatric patients suffering from obesity in the 30 to 40 BMI range. The treatment group underwent gastric balloon placement and removal after 6 months, while at the same time taking part in the 12-month behavior modification program. The control group participated in the behavior modification program only.

At 6 months, the Orbera treatment group lost more than three times as much weight as the control group. The gastric balloon group also lost significantly more weight than the control group over the course of the study and maintained significant weight loss after 12 months.